Lucid Diagnostics (LUCD) Net Margin Growth (1y) (2022 - 2026)
Lucid Diagnostics (LUCD) Net Margin Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -860.00 |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 469.00 |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 94.00 |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 92.00 |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -777.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 350.00 |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 85.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -81.00 |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 67.00 |
| 10 | Lucid Diagnostics | 176.73 Mn | 143.33 Mn | 55,000.00 | -30,275.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -30,275.00 |
| Mar 31, 2026 | 253,462.00 |
| Dec 31, 2025 | -12,396.00 |
| Sep 30, 2025 | 19,700.00 |
| Jun 30, 2025 | 47,023.00 |
| Mar 31, 2025 | -254,101.00 |
| Dec 31, 2024 | 7,719.00 |
| Sep 30, 2024 | 75,901.00 |
| Jun 30, 2024 | 603,030.00 |
| Mar 31, 2024 | 183,383.00 |
| Dec 31, 2023 | 1.23 Mn |
| Sep 30, 2023 | 1.71 Mn |
| Mar 31, 2023 | 284,924.00 |
| Dec 31, 2022 | -955,990.00 |
| Sep 30, 2022 | -1.54 Mn |